My Companies
Notification
Account
Log Out
Login
Board approved raising up to Rs65 crore via rights issue of equity or convertibles to eligible shareholders, record date to be notified, subject to shareholder and regulatory approvals, and constituted Rights Issue Committee. Context: first dilution attempt after no equity raise in recent years.
Aspira Pathlab Approves ₹65 Crore Rights Issue Subject To Approvals
Aspira Pathlab & Diagnostics Board Approves ₹65 Crore Rights Issue
Aspira Pathlab & Diagnostics Approves ₹65 Crore Rights Issue Subject To Approvals
Aspira Pathlab Schedules September 12 Board Meeting To Consider Fundraising
Aspira Pathlab & Diagnostics Promoter Jay Bhanushali Buys 332 Shares